Stock Analysis

Discovering Creative & Innovative System And 2 Other Hidden South Korean Small Cap Gems

Published

Over the last 7 days, the South Korean market has risen 7.9%, although its performance over the past year has remained flat. With earnings expected to grow by 28% per annum over the next few years, now is an opportune time to explore some lesser-known small-cap stocks that show potential for innovation and growth.

Top 10 Undiscovered Gems With Strong Fundamentals In South Korea

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Korea Airport ServiceLtdNA0.40%27.17%★★★★★★
Korea Cast Iron Pipe IndNA2.58%14.14%★★★★★★
NOROO PAINT & COATINGS17.16%5.11%6.31%★★★★★★
ASIA Holdings34.13%8.28%15.67%★★★★★★
Woori Technology InvestmentNA22.60%-1.67%★★★★★★
Kyungdong Invest8.15%3.08%15.07%★★★★★★
Oriental Precision & EngineeringLtd59.19%3.54%5.92%★★★★★★
Hansae Yes24 Holdings97.82%2.74%18.89%★★★★★☆
KG Chemical43.62%33.46%8.39%★★★★★☆
Ubiquoss Holdings2.69%9.93%14.22%★★★★★☆

Click here to see the full list of 202 stocks from our KRX Undiscovered Gems With Strong Fundamentals screener.

Here's a peek at a few of the choices from the screener.

Creative & Innovative System (KOSDAQ:A222080)

Simply Wall St Value Rating: ★★★★★☆

Overview: Creative & Innovative System Corporation manufactures and sells equipment for lithium-ion batteries powering IT instruments, EV lithium-ion batteries, fuel cells, solar cells, and displays with a market cap of ₩758.18 billion.

Operations: The company generates revenue primarily from the sale of machinery and industrial equipment, amounting to ₩378.93 billion.

Creative & Innovative System, a small-cap company in South Korea, has shown impressive performance with earnings growth of 417.1% over the past year, significantly outpacing the Machinery industry’s -3.5%. The company's debt to equity ratio improved from 49% to 6.6% in five years, indicating better financial health. Despite this progress, shareholders experienced dilution in the past year. Future earnings are projected to grow at an annual rate of 25.8%, suggesting continued potential for expansion.

KOSDAQ:A222080 Debt to Equity as at Aug 2024

Daewoong (KOSE:A003090)

Simply Wall St Value Rating: ★★★★★★

Overview: Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea, with a market cap of ₩936.40 billion.

Operations: Revenue primarily comes from pharmaceutical manufacturing and sales (₩1.98 trillion) and service provision (₩120.70 billion), with additional income from real estate rental (₩11.88 billion).

Daewoong's debt to equity ratio has improved from 39.7% to 32.2% over five years, reflecting prudent financial management. Despite a volatile share price recently, the company’s net debt to equity ratio stands at a satisfactory 14.4%. Earnings have grown by an impressive 23.6% annually over the past five years, although last year's growth of 15.1% lagged behind the industry average of 18.9%. With a P/E ratio of just 6.9x compared to the KR market's 11.7x, Daewoong offers good value and high-quality earnings backed by strong EBIT coverage of interest payments at 43 times.

KOSE:A003090 Debt to Equity as at Aug 2024

Kyung Dong Navien (KOSE:A009450)

Simply Wall St Value Rating: ★★★★★★

Overview: Kyung Dong Navien Co., Ltd. manufactures and sells machinery and heat combustion equipment in South Korea, with a market cap of ₩966.90 billion.

Operations: Kyung Dong Navien generates revenue primarily through the sale of machinery and heat combustion equipment. The company has a market cap of ₩966.90 billion.

Kyung Dong Navien, a small cap in South Korea, has shown impressive earnings growth of 27.8% over the past year, outpacing the Building industry’s 16.2%. The company’s net debt to equity ratio stands at a satisfactory 1.9%, and its interest payments are well covered by EBIT at 20.1x coverage. Additionally, Kyung Dong Navien's price-to-earnings ratio is favorable at 11.6x compared to the KR market average of 11.7x, indicating good value for investors seeking quality earnings and robust financial health.

KOSE:A009450 Debt to Equity as at Aug 2024

Make It Happen

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Kyung Dong Navien might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com